In The Aftermath Of The Pandemic, Cancer Screenings Are Rebounding With A Vengeance.

0
209
In The Aftermath Of The Pandemic, Cancer Screenings Are Rebounding With A Vengeance.

In the months after the COVID-19 pandemic, the decline in most cancer screening tests, a major U.S. hospital system shows, rebounded dramatically. This study used data from Massachusetts General Brigham’s Boston system to uncover preliminary findings. Depending on the type of test, cancer screenings declined by 65 to 82 percent between March and June of 2020, whereas they decreased from June to September by 4 to 44%.

In The Aftermath Of The Pandemic, Cancer Screenings Are Rebounding With A Vengeance.

Drop-offs could be brief in some cases. The study found that screening levels for cervical, breast, lung cancer, and prostate exceeded those of pre-pandemic times between September and December of 2020. Although colonoscopy screening for detecting colon cancer didn’t return to normal, it has continued to decline.

In The Aftermath Of The Pandemic, Cancer Screenings Are Rebounding With A Vengeance.

A study co-authored by Dr. Chris Labaki of the Dana Farber Cancer Institute located in Boston said that the increased screening tests from September to December 2020 allowed recovery of some of the overlooked cancer diagnoses from previous times. She also added that more work needs to be done to implement adequate screening programs, as there are still a significant amount of cancers that go undiagnosed.

Researchers think colonoscopy has not rebounded due to its invasive nature and the need for anesthesia, making it the most invasive of cancer screening tests. In some cases, patients may have chosen to do home stool tests rather than seeking medical attention.

Even though the majority of screenings have risen, fewer cancer diagnoses have occurred in the early stages of the pandemic, which could have long-term consequences.

One thousand eight hundred and ninety-five positive tests were reported between March and June last year, compared to three thousand and forty-six between September and December of this year. A Dana-Farber news release reported that 1,187 cancer diagnoses were missed due to reduced screening during the period March to June 2020.

It is unclear whether the diagnosis of the 323 cancers had been found at a later stage by the time the study was conducted in September and December 2020. Over the study period, no evidence of any colonoscopy-related diagnosis was found, and 38 clinically significant diagnoses went undiagnosed.

Furthermore, the investigators discovered that disparities between whites and blacks widened. Between September and December 2020, mammograms performed on women decreased overall, but Hispanic women and Black women received less of them than they did in the 3 months prior to the pandemic started.

In their conclusion, the authors conclude that these results are concerning and suggest that there may be racial disparities when it comes to cancer screening. As an opinion letter in Cancer Cell, the findings have recently been published.

As a result of the growing screening gap due to COVID-19, co-author Dr. Quoc-Dien Trinh predicted that differences in cancer survival rates will worsen racial disparities. Co-Director of the Dana-Farber/Brigham & Women’s Cancer Center, Trinh is a prostate cancer expert.

Dr. Toni Choueiri, director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute and study co-author, says that delayed diagnosis may adversely affect some patients.

When a person has no symptoms, cancer screening is done to check for cancer. Other factors to consider:

Cancer can be detected early with screening tests. The sooner cancer or abnormal tissue is detected, the more easily it can be treated or cured. Cancer may have spread and grown by the time symptoms appear. Treatment and cure of cancer may be more difficult because of this. The doctor does not always suggest a screening test because he or she believes that you have cancer. Cancer screenings are done when there are no symptoms of the disease.

  • Various screening tests are available.
  • There are risks associated with testing.
  • Detecting cancer early is done through cancer screening.
  • Screening tests can lead to serious complications.
  • False-positive results can occur during a test.
  • Tests can result in false negatives.
  • A person may not live longer or live healthier after discovering cancer.

LEAVE A REPLY

Please enter your comment!
Please enter your name here